CSS
RAPT

Cubist Systematic Strategies’s RAPT Therapeutics RAPT Stock Holding History

Cubist Systematic Strategies’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,940
Closed -$112K – 3461
2024
Q3 		$112K Sell
6,940
-29,965
-81% -$606K ﹤0.01% 2679
2024
Q2 		$900K Buy
36,905
+32,921
+826% +$1.52M 0.01% 1798
2024
Q1 		$286K Buy
3,984
+3,653
+1,104% +$508K ﹤0.01% 2900
2023
Q4 		$65.9K Buy
+331
New +$41K ﹤0.01% 3238
2023
Q2 		– Sell
-978
Closed -$144K – 4164
2023
Q1 		$144K Buy
+978
New +$198K ﹤0.01% 3360
2022
Q1 		– Sell
-1,117
Closed -$328K – 3733
2021
Q4 		$328K Sell
1,117
-1,095
-50% -$293K ﹤0.01% 2741
2021
Q3 		$549K Buy
+2,212
New +$585K 0.01% 1974

Other funds holding RAPT

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cubist Systematic Strategies's RAPT Position: Q4 2024 in Review

Cubist Systematic Strategies sold out of RAPT Therapeutics (RAPT) in Q4 2024, closing a stake of 6,940 shares — an estimated $112K sold.

Cubist Systematic Strategies first reported a position in RAPT in Q3 2021 and held it in 7 quarters. The position peaked at $900K in Q2 2024. 91 funds tracked by Wall St. Rank hold RAPT as of Q4 2024.

  • Cubist Systematic Strategies reported no remaining RAPT Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 6,940 RAPT Therapeutics shares in Q4 2024, an estimated $112K.
  • Cubist Systematic Strategies first reported a position in RAPT Therapeutics in Q3 2021 and held it in 7 quarters.
  • Cubist Systematic Strategies's RAPT Therapeutics position peaked at $900K in Q2 2024.
  • 91 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q4 2024.

Based on Cubist Systematic Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.